SpringWorks Therapeutics Inc. (SWTX)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 348 |
| % of all portfolios: | 0.028% |
| Hold Price * : | $33.24 |
| History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
| Q3 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 6.84% | 177,824 | 0.11 | |
| Q2 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 36.25% | 691,894 | 0.49 | |
| ≡ | Meridian Contrarian Fund | Buy | 66,000 | 0.47 | |
| Q1 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 33.57% | 964,586 | 0.92 | |
| Q4 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 350.52% | 2,235,456 | 1.68 | |
| ≡ | Meridian Contrarian Fund | Sell 100.00% | 37,000 | 0.16 | |
| Q3 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 637,760 | 0.34 | |
| ≡ | Meridian Contrarian Fund | Reduce 68.38% | 80,000 | 0.35 | |
| Q4 2022 | |||||
| ≡ | Meridian Contrarian Fund | Add 6.36% | 7,000 | 0.03 | |
| Q2 2022 | |||||
| ≡ | Meridian Contrarian Fund | Add 92.98% | 53,000 | 0.25 | |
| Q1 2022 | |||||
| ≡ | Meridian Contrarian Fund | Buy | 57,000 | 0.50 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.